Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 23, Issue 2, 2003, Pages 174-183

  Chung, Sung Hee ^a,b   Heimbürger, Olof ^a   Stenvinkel, Peter ^a   Wang, Tao ^a   Lindholm, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Soonchunhyang University   (South Korea)

Author keywords

Fluid removal; Inflammation; Mortality; Nutrition; Peritoneal transport rate

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; NITROGEN; SERUM ALBUMIN; UREA;

ADULT; AGE; AGED; ARTICLE; CHEMICAL ANALYSIS; CLEARANCE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIALYSATE LEVEL; DISEASE COURSE; EXTRACELLULAR FLUID; FEMALE; GLUCOSE ABSORPTION; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIVARIATE ANALYSIS; NIGHT; NUTRITIONAL STATUS; PATIENT CODING; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; SOLUTE; SURVIVAL RATE; TREATMENT CONTRAINDICATION; ULTRAFILTRATION;

EID: 0037357206     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300214     Document Type: Article

References (55)

1. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
2. Chung SH, Chu WS, Lee HA, Kim YH, Lee IS, Lindholm B, et al. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients. Perit Dial Int 2000; 20:541-7.
3. Mailloux LU, Napolitano B, Bellucci AG, Mossey RT, Vernace MA, Wilkes BM. The impact of co-morbid risk factors at the start of dialysis upon the survival of ESRD patients. ASAIO J 1996; 42:164-9.
4. Chung SH, Lindholm B, Lee HB. Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int 2000; 20:19-26.
5. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcome. J Am Soc Nephrol 1996; 7:198-207.
6. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998; 18:387-94.
7. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55:648-58.
8. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35:469-76.
9. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10:2295-305.
10. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study. J Am Soc Nephrol 2001; 12:2158-62.
11. Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000; 58:446-57.
12. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285-92.
13. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
14. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57:314-20.
15. Nolph KD, Moore HL, Prowant B, Twardowski ZJ, Khanna R, Gamboa S, et al. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report. ASAIO J 1993; 39:M566-M568.
16. Heaf J. CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Ren Fail 1995; 17:575-87.
17. Cueto-Manzano AM, Espinosa A, Hernandez A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis 1997; 30:229-36.
18. Fung L, Pollock CA, Caterson RJ, Mahony JF, Waugh DA, Macadam C, et al. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1996; 7:737-44.
19. Wang T, Lindholm B. Beyond CANUSA, DOQI, ADEMEX: what's next? Perit Dial Int 2002; 22:555-62.
20. Freeman L, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 1994; 52: 340-7.
21. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999; 353(9167):1838-42.
22. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-911.
23. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953-60.
24. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
25. Wang T, Heimbürger O, Cheng HH, Bergström J, Lindholm B. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999; 19:17-22.
26. Heimbürger O, Wang T, Chung SH, Ohlsson S, Lindholm B, Stenvinkel P. Increased peritoneal transport rate from an early peritoneal equilibration test (PET) is related to inflammation, cardiovascular disease and mortality [Abstract]. J Am Soc Nephrol 1999; 10:315A.
27. Heaf J. Pathogenic effects of a high peritoneal transport rate. Semin Dial 2000; 13:188-93.
28. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
29. Twardowski ZJ. PET - a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990; 6:186-91.
30. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27-39.
31. Bergström J, Heimbürger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998; 18:467-73.
32. Metropolitan Life Insurance Company. Metropolitan height and weight tables. Statistics Bull 1983; 64: Jan-June.
33. Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, et al. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4:1475-85.
34. Mitch WE, Walser M. A proposed mechanism for reduced creatinine excretion in severe chronic renal failure. Nephron 1978; 21:248-54.
35. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976; 29:1359-66.
36. Stenvinkel P, Heimbürger O, Tuck CH, Berglund L. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998; 53:1336-42.
37. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14:1956-60.
38. McIntyre C, Harper I, Macdougall IC, Raine AE, Williams A, Baker LR. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. Clin Nephrol 1997; 48:371-4.
39. Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16:2240-5.
40. Fine A. Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 2002; 61:615-20.
41. Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22:97-101.
42. Kang DH, Yoon KI, Choi KB, Lee R, Lee HY, Han DS, et al. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients. Nephrol Dial Transplant 1999; 14:1715-22.
43. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study. Am J Kidney Dis 2001; 37:329-36.
44. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Time dependence of solute removal during a single exchange. Adv Perit Dial 1997; 13:23-8.
45. Bergström J. Appetite in CAPD patients. Perit Dial Int 1996; 16(Suppl 1):S181-4.
46. Kaysen GA. Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998; 9:2368-76.
47. Brockhaus M, Bar-Khayim Y, Gurwicz S, Frensdorff A, Haran N. Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int 1992; 42:663-7.
48. Pereira BJ, Dinarello CA. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994; 9(Suppl 2):60-71.
49. Herbelin A, Urena P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39:954-60.
50. Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, et al. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int 2000; 58:417-24.
51. Bemelmans MH, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 1993; 150:2007-17.
52. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154:882-92.
53. Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000; 36:1213-25.
54. Chandra RK. Nutrition, immunity, and infection: present knowledge and future directions. Lancet 1983; 1:688-91.
55. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.